MedComm | Plasma pTau181 as a biomarker for Alzheimer's disease
Alzheimer's disease (AD) is one of the most difficult neurological disorders, because there are no means of biomarkers to predict the disease progression, nor is there a cure. Recently, on Nature Medi....
MedComm | The challenges of the COVID‐19 pandemic: Approaches for the elderly and those with Alzheimer's disease
The COVID-19 outbreak has brought challenges to societies around the globe, especially for some special communities. In this article, Qing Zhang et al reviewed some unique challenges the elderly and p....
MedComm - Plasma therapy cured a COVID‐19 patient with long duration of viral shedding for 49 days
COVID-19 has spread worldwide since it began in late 2019, becoming a threat to global health. Recently, Li Tan et al reported a special case of a family cluster with a mild type of COVID‐19, in which....